Table 3.
Property | Maps generated in this review |
---|---|
Known-groups validity |
Number and proportion of analyses per DMO and medical condition, which found a statistically significant difference (1) between pathological and healthy gait, or (2) between disease severity strata |
Convergent validity | Number and proportion of analyses per DMO and medical condition, which found a statistically significant, cross-sectional association between a DMO and validated measures of relevant constructs (e.g., disease severity, physical function, health-related quality of life, etc.) |
Predictive validity | Number and proportion of analyses per DMO and medical condition, which found a statistically significant association between a DMO measured at baseline and a clinically relevant outcome at follow-up (i.e., mortality, physical function, healthcare utilization, etc.) |
Responsiveness to intervention | Number and proportion of analyses per DMO and medical condition, which found a significant difference between experimental and control groups in an interventional study |
Ecological validity | DMOs measured in clinical and real-world settings were mapped separately and trends were compared qualitatively |